Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
A completed clinical trial investigating renal hemodynamics, energetics, and insulin resistance in subjects with type 2 diabetes, with resul…
-
CLINICAL_TRIALS other · 2026-04-24Clinical Trial Update: Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
The clinical trial investigating the molecular and clinical profile of type 2 diabetes mellitus and its complications, including diabetic ne…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Hyperbaric Oxygen Therapy for Renal Regeneration in Diabetic Nephropathy [NA]
This clinical trial investigating hyperbaric oxygen therapy for renal regeneration in diabetic nephropathy was terminated.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial sponsored by Brigham and Women's Hospital is recruiting to prevent cardiovascular disease and diabetic kidney disea…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: NAD Augmentation in Diabetes Kidney Disease [Phase 2]
Phase 2 clinical trial evaluating NAD augmentation for diabetic kidney disease in adults with type 2 diabetes; currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
The Family Investigation of Nephropathy and Diabetes (F.I.N.D.) trial registry entry describes an NIDDK-supported study on diabetic nephropa…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of WAL0921 in Patients With Glomerular Kidney Diseases [Phase 2]
Walden Biosciences reports a Phase 2 clinical trial of WAL0921 in multiple glomerular diseases, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease [Phase 2]
A Phase 2 clinical study evaluating the efficacy and safety of levocetirizine in patients with diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria [Phase 2]
A Phase IIb study by Curacle evaluating CU01-1001 for 24 weeks in adults with type 2 diabetes and albuminuria; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status
This completed trial investigates salivary and serum inflammatory biomarkers in diabetic nephropathy and how periodontal status (periodontit…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease [Phase 3]
Phase 3 clinical trial update evaluating sotagliflozin to slow kidney function decline in adults with Type 1 diabetes and diabetic kidney di…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial [NA]
Protocol for a controlled clinical trial at Steno Diabetes Center Copenhagen evaluating digital support to reduce salt intake in patients wi…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus
This clinical trial update explores whether the ratio of non-HDL cholesterol to HDL cholesterol (NHHR) is associated with the development of…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients
This clinical trial investigates irisin hormone as a diagnostic marker for detecting and monitoring the progression of diabetic nephropathy.…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence [NA]
This entry notes an ongoing clinical trial exploring AI- and multi-omics–driven Traditional Chinese Medicine approaches for diabetic nephrop…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating whether human umbilical cord–derived mesenchymal stem cells can prevent arteriovenous fistula stenosis…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes [NA]
This document is a clinical trial update describing the study of pyridoxamine supplementation and its effects on microvascular function in i…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Transformative Research in Diabetic Nephropathy 2.0
Clinical trial update announcing that a study on transformative research in diabetic nephropathy is currently recruiting, covering diabetic …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Transformative Research in Diabetic Nephropathy
The University of Pennsylvania-led study on diabetic nephropathy is currently recruiting participants. It targets diabetic nephropathy and r…
-
FDA approval · 2026-02-18FDA Approved: ARBLI — Supplemental Application (Scienture LLC)
FDA approved a supplemental application for ARBLI (losartan potassium) filed by Scienture LLC.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
The SPeCTRuM trial, sponsored by the Jaeb Center for Health Research, is currently recruiting. It studies CFRD-related complications in cyst…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the safety and efficacy of allogeneic umbilical cord mesenchymal stem cell therapy in patients with di…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes [Phase 2]
Phase 2 pilot trial evaluating fenofibrate to prevent kidney function decline in people with type 1 diabetes; the study is currently active …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Formoterol in Diabetes [Phase 2]
Phase 2 clinical trial investigating formoterol for diabetic nephropathy and diabetic kidney disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease [Phase 2]
A Phase 2 clinical trial investigating inflammation and stem cell approaches in diabetic nephropathy and chronic kidney disease is currently…